Develop Three Novel Bispecific ADC Programs

Merus NV

13/01/2025 01:08

Jan 12 (Reuters) - Merus NV  2GH.F :
    * MERUS AND BIOHAVEN ANNOUNCE COLLABORATION TO CO-DEVELOP
THREE
NOVEL BISPECIFIC ADC PROGRAMS
    * BIOHAVEN LTD - CO IS RESPONSIBLE FOR PRECLINICAL ADC
GENERATION
OF THREE MERUS BISPECIFIC ANTIBODIES UNDER MUTUALLY AGREED
RESEARCH PLANS
    * BIOHAVEN - AGREEMENT INCLUDES TWO MERUS BISPECIFIC
PROGRAMS
GENERATED USING BICLONICS PLATFORM
    * BIOHAVEN LTD - MERUS WILL RECEIVE AN UPFRONT PAYMENT AND
LICENSE
FEE AT ADC CANDIDATE NOMINATION OF FIRST PROGRAM

Source text:  ID:nGNX47y28G 
Further company coverage:  2GH.F 

 ((Reuters.Briefs@thomsonreuters.com;))